Development of an adherence to Iron-Chelation Therapy measure through a qualitative study: patient and caregiver perspectives in transfusion-dependent anemias and myelodysplastic syndrome

被引：0
|
作者：
Lasch, Kathryn E. [1 ]
Horodniceanu, Erica G. [1 ]
Bal, Vasudha [2 ]
Cote, Isabelle [2 ]
Dorgan, Amy [2 ]
Malet, Isabelle [2 ]
机构：
[1] Pharmerit Int, Cambridge, MA USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
QUALITY OF LIFE RESEARCH | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2013
引用
收藏
页码：105 / 105
页数：1
相关论文
共 29 条
  • [21] Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
    Horodniceanu, Erica G.
    Bal, Vasudha
    Dhatt, Harman
    Carter, John A.
    Huang, Vicky
    Lasch, Kathryn
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [22] A RISK EQUATION TO ESTIMATE IRON OVERLOAD-RELATED COMPLICATION RATES BASED ON ADHERENCE RATES OF IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA
    Huang, V. W.
    Kuizenga, P.
    Barbier, M.
    Kessabi, S.
    VALUE IN HEALTH, 2016, 19 (03) : A250 - A251
  • [23] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplastic
    Delea, TE
    Thomas, SK
    Baladi, JF
    Phatak, PD
    BLOOD, 2005, 106 (11) : 484B - 485B
  • [24] Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
    Musto, Pellegrino
    Maurillo, Luca
    Simeon, Vittorio
    Poloni, Antonella
    Finelli, Carlo
    Balleari, Enrico
    Ricco, Alessandra
    Rivellini, Flavia
    Cortelezzi, Agostino
    Tarantini, Giuseppe
    Villani, Oreste
    Mansueto, Giovanna
    Milella, Maria R.
    Scapicchio, Daniele
    Marziano, Gioacchino
    Breccia, Massimo
    Niscola, Pasquale
    Sanna, Alessandro
    Clissa, Cristina
    Voso, Maria T.
    Fenu, Susanna
    Venditti, Adriano
    Santini, Valeria
    Angelucci, Emanuele
    Levis, Alessandro
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (05) : 741 - 750
  • [25] Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670)
    Di Tucci, Anna Angela
    Murru, Roberta
    Alberti, Daniele
    Rabault, Bertrand
    Deplano, Simona
    Angelucci, Emanuele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (06) : 540 - 542
  • [26] Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study
    Lin, Chien-Heng
    Chen, Xianxiu
    Wu, Chin-Ching
    Wu, Kang-Hsi
    Song, Ta-Shu
    Weng, Te-Fu
    Hsieh, Yow-Wen
    Peng, Ching-Tien
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (04) : 265 - 272
  • [27] Iron chelation therapy in transfusion dependent patients with myelodysplastic syndrome with transfusional iron-overload in routine clinical management - interim analysis of the non-interventional study EXSEPT
    Nolte, F.
    Rubanov, O.
    Kuehn, R-B
    Schumann, C.
    Kreil, S.
    Metzgeroth, G.
    Junkes, A.
    Johr, C.
    Albrecht, S.
    Hofmann, W-K
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 251 - 251
  • [28] Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial
    Angelucci, Emanuele
    Santini, Valeria
    Di Tucci, Anna Angela
    Della Casa, Chiara
    Finelli, Carlo
    Volpe, Antonio
    Pogliani, Enrico Maria
    Quarta, Giovanni
    Levis, Alessandro
    D'Arco, Alfonso Maria
    Saglio, Giuseppe
    Cascavilla, Nicola
    Morra, Enrica
    Vallisa, Daniele
    Foa, Robin
    Leone, Giuseppe
    Storti, Sergio
    Gabbas, Attilio
    Annino, Luciana
    Magro, Domenico
    Tosi, Patrizia
    Caocci, Giovanni
    Musto, Pellegrino
    Amadori, Sergio
    Leoni, Pietro
    Gobbi, Marco
    Piciocchi, Alfonso
    Vignetti, Marco
    Porcedda, Serenella
    Tura, Sante
    BLOOD, 2010, 116 (21) : 1206 - 1206
  • [29] Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations
    Nolte, Florian
    Angelucci, Emanuele
    Breccia, Massimo
    Gattermann, Norbert
    Santini, Valeria
    Vey, Norbert
    Hofmann, Wolf-Karsten
    LEUKEMIA RESEARCH, 2015, 39 (10) : 1028 - 1033
123